• Find people
• Intranet

Agenda

20/10/2017

Optimizing Immunotherapy: New Approaches, Biomarkers, Sequences and Combinations

• Add to my Outlook calendar
• Add to my Google calendar

Auditori del PRBB de 9 a 17 hores

Aquesta jornada es va celebrar el dia 20 d'octubre i us facilitem els enllaços a les presentacions que es van portar a terme:

PROGRAMA

• Welcome and Opening. Joaquim Bellmunt
• Where we stand in Immunotherapy:IO+IO Combinations. Ignacio Melero

TABLE 1-Immnotherapy in the clinic. Moderator: Joaquim Bellmunt

• Melanoma. Jose Luis Manzano
• Lung. Marga Majem
• Genitourinary. Enrique Gallardo

TABLE 2-Biomarkers in immunotherapy. Moderator: Joan Albanell 

• PDL1 as a predictive biomarker: pros and cons. Edurne Arriola
• HLA expression: implications for immunotherapy. Aura Muntasell 
• Predictive value of the Mutational load, neoantigens and clonal antigens. Somatic and germline genomic alterations. Beatriz Bellosillo 
• RNA Signatures as predictive biomarker. Joan Carles 
• Microbiome as predictor of benefit and toxicity. Giulana Magri 
• Commercially available tests and their predictive role. Teresa Ramos 
• The role of tumor-infiltrating lymphocytes in immunotherapy. Federico Rojo 

TABLE 3. What the future holds. Moderador: Edurne Arriola

• Combination and sequencing:with radiation therapy, with chemotherapy and with targeted therapies. Josep MªPiulats
• Other immunotherapeutic approaches: new check point inhibitors and antibody drug conjugates. Maria Martínez
• Vaccines. Begoña Mellado
• CARTs: Driving T-lymphocytes as a cell immunotherapy. Manel Juan

MÉS INFORMACIÓ:

• Programa
• Imatges de la Jornada
• Storify de l'acte

More events